Enpro
NPO
317.68
-14.38
-4.33%
Enpro
US · NPO
#1777 by market cap
Listed 1970
317.68
-14.38
-4.33%
Live - 5344 symbols - heartbeat 251s ago
· 2026-10-08 08:10
Pre-market
315.38
-0.72%
After-hours
317.68
0.00%
- Market cap
- 6.72B
- P/E (TTM)i
- 154.21
- P/Bi
- 4.24
- EPSi
- 1.91
- Div yieldi
- 0.40%
- 52W posi
- 62%
Reader sentiment
Are you bullish or bearish on NPO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.98, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +9.02% YoY
Margins
- Gross margin
- 42.64%
- Operating margin
- 14.35%
- Net margin
- 3.54%
Key ratios & quality
- Enterprise valuei
- 7.28B
- Altman Z-Scorei
- 4.98
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.27B | 1.21B | 800.00M | 840.40M | 1.10B | 1.06B | 1.05B | 1.14B |
| Gross profit | 418.50M | 403.80M | 285.50M | 328.10M | 423.30M | 426.80M | 444.80M | 487.50M |
| Selling & admin expenses | 311.60M | 314.90M | 230.20M | 260.30M | 282.80M | 284.20M | 296.30M | 323.40M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 85.80M | 56.60M | 29.10M | 65.40M | 140.40M | 142.60M | 148.50M | 164.10M |
| Pretax profit | 15.10M | 4.30M | -23.50M | 66.00M | 28.30M | 37.70M | 94.40M | 57.60M |
| Tax | 19.80M | -3.50M | -2.50M | 8.70M | 24.40M | 30.80M | 21.50M | 17.10M |
| Net profit | 19.60M | 38.30M | 178.00M | 178.30M | 202.30M | 18.30M | 72.90M | 40.50M |
| Basic EPS | 1 | 2 | 9 | 9 | 10 | 1 | 3 | 2 |
| Diluted EPS | 0.94 | 1.85 | 8.64 | 8.57 | 9.83 | 1.05 | 3.45 | 1.91 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 273.20M | 288.10M | 286.60M | 295.40M | 303.00M | 338.80M |
| Gross profit | 118.20M | 124.80M | 120.20M | 124.30M | 130.00M | 149.00M |
| Selling & admin expenses | 75.80M | 79.20M | 78.90M | 89.60M | 85.30M | 89.80M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 41.80M | 45.70M | 40.90M | 35.70M | 43.50M | 57.70M |
| Pretax profit | 32.30M | 35.50M | 32.10M | -42.30M | 33.90M | 32.90M |
| Tax | 7.80M | 9.10M | 10.50M | -10.30M | 6.50M | 5.80M |
| Net profit | 24.50M | 26.40M | 21.60M | -32.00M | 27.40M | 27.10M |
| Basic EPS | 1 | 1 | 1 | -2 | 1 | 1 |
| Diluted EPS | 1.15 | 1.25 | 1.01 | -1.52 | 1.29 | 1.27 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 732.10M | 749.50M | 579.00M | 804.70M | 684.20M | 650.30M | 512.30M | 437.70M |
| Cash & ST investments | 129.60M | 121.20M | 229.50M | 338.10M | 334.40M | 369.80M | 236.30M | 114.70M |
| Inventory | 174.20M | 157.10M | 139.10M | 135.90M | 151.90M | 142.60M | 138.80M | 153.80M |
| Total assets | 1.72B | 2.04B | 2.08B | 2.97B | 2.65B | 2.50B | 2.49B | 2.66B |
| Total current liabilities | 292.00M | 313.60M | 202.00M | 386.30M | 211.50M | 196.40M | 198.00M | 188.70M |
| Short-term debt | 2.40M | 13.40M | 13.90M | 171.50M | 24.80M | 18.10M | 26.20M | 12.90M |
| Long-term debt | 462.50M | 625.20M | 487.50M | 963.90M | 775.10M | 638.70M | 624.10M | 655.10M |
| Total liabilities | 858,100,000.00 | 1,120,200,000.00 | 956,700,000.00 | 1,654,200,000.00 | 1,234,800,000.00 | 1,071,900,000.00 | 1,062,900,000.00 | 1,119,100,000.00 |
| Total equity | 857.70M | 914.90M | 1.13B | 1.32B | 1.41B | 1.43B | 1.43B | 1.54B |
| Retained earnings | 603.30M | 632.20M | 794.80M | 953.10M | 1.13B | 1.13B | 1.18B | 1.19B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 544.20M | 424.70M | 457.00M | 437.70M | 433.20M | 455.20M |
| Cash & ST investments | 240.30M | 107.10M | 132.90M | 114.70M | 79.20M | 77.00M |
| Inventory | 136.50M | 143.30M | 141.60M | 153.80M | 158.70M | 169.60M |
| Total assets | 2.51B | 2.38B | 2.40B | 2.66B | 2.64B | 2.66B |
| Total current liabilities | 184.30M | 170.40M | 187.10M | 188.70M | 196.50M | 199.50M |
| Short-term debt | 26.50M | 11.30M | 11.70M | 12.90M | 12.60M | 13.20M |
| Long-term debt | 620.40M | 464.90M | 445.00M | 655.10M | 605.20M | 575.30M |
| Total liabilities | 1,044,800,000.00 | 879,200,000.00 | 877,700,000.00 | 1,119,100,000.00 | 1,072,800,000.00 | 1,073,100,000.00 |
| Total equity | 1.46B | 1.50B | 1.52B | 1.54B | 1.56B | 1.59B |
| Retained earnings | 1.19B | 1.21B | 1.23B | 1.19B | 1.21B | 1.23B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 226.40M | 207.60M | 50.60M | 141.90M | 127.40M | 207.80M | 162.90M | 201.20M |
| Depreciation & amortization | 66.10M | 67.90M | 56.60M | 63.80M | 103.10M | 94.50M | 100.30M | 102.80M |
| Free cash flow | 190.30M | 186.00M | 37.20M | 127.00M | 97.60M | 173.50M | 130.00M | 153.10M |
| Dividends paid | -20.30M | -20.90M | -21.70M | -22.40M | -23.40M | -24.30M | -25.30M | -26.20M |
| Stock buybacks / issuance | -50.00M | -15.00M | 0 | 10.00M | -- | -- | -- | -- |
| Ending cash balance | 129.60M | 121.20M | 229.50M | 338.10M | 334.40M | 369.80M | 236.30M | 114.70M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 21.00M | 52.20M | 65.30M | 62.70M | 39.60M | 51.30M |
| Depreciation & amortization | 25.20M | 25.20M | 25.20M | 27.20M | 27.50M | 27.10M |
| Free cash flow | 11.60M | 41.20M | 52.10M | 48.20M | 26.50M | 34.90M |
| Dividends paid | -6.60M | -6.60M | -6.50M | -6.50M | -6.90M | -6.90M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 240.30M | 107.10M | 132.90M | 114.70M | 79.20M | 77.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 2.79 | 4.38 | 18.76 | 15.15 | 15.41 | 1.58 | 5.14 | 2.73 |
| ROA %i | 1.36 | 2.04 | 8.95 | 7.03 | 7.30 | 0.86 | 2.92 | 1.57 |
| ROIC %i | 3.13 | 3.62 | 12.71 | 9.49 | 10.09 | 2.16 | 4.80 | 2.81 |
| 5-year avg ROE %i | 15.54 | 15.71 | 20.10 | 25.09 | 11.05 | 10.92 | 11.07 | 8.00 |
| EBIT margin %i | 4.90 | 1.98 | -0.96 | 20.03 | 5.81 | 7.81 | 12.90 | 8.01 |
| FCF / sales %i | 10.47 | 15.43 | 3.08 | 10.79 | 8.92 | 16.42 | 12.40 | 13.39 |
| Current ratioi | 2.51 | 2.39 | 2.87 | 2.08 | 3.23 | 3.31 | 2.59 | 2.32 |
| Quick ratioi | 1.17 | 0.99 | 2.09 | 1.25 | 2.23 | 2.48 | 1.78 | 1.32 |
| Debt / assetsi | 27.10 | 31.38 | 24.06 | 38.17 | 30.21 | 26.28 | 26.10 | 25.08 |
| LT debt / equityi | 53.92 | 70.49 | 45.20 | 75.88 | 55.56 | 45.31 | 43.69 | 42.43 |
| Interest coveragei | 2.64 | 1.22 | -0.62 | 14.03 | 1.79 | 1.84 | 3.31 | 2.69 |
| Revenue CAGR (3Y) %i | 1.89 | 0.50 | -10.11 | -12.95 | -3.04 | 9.81 | 7.66 | 1.32 |
| Net income CAGR (3Y) %i | -- | -- | -30.96 | 108.60 | 74.95 | -50.00 | -25.72 | -41.77 |
| FCF CAGR (3Y) %i | 61.59 | 96.27 | 31.66 | -12.61 | -19.34 | 67.08 | 0.78 | 16.19 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 5.90 | 5.78 | 5.80 | 2.73 | 2.87 | 2.86 |
| ROA %i | 3.37 | 3.46 | 3.50 | 1.57 | 1.69 | 1.75 |
| ROIC %i | 5.26 | 5.36 | 5.28 | 2.81 | 3.02 | 3.25 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 14.30 | 13.84 | 13.94 | 8.01 | 7.96 | 7.40 |
| FCF / sales %i | 13.49 | 13.63 | 13.75 | 13.39 | 14.32 | 13.21 |
| Current ratioi | 2.95 | 2.49 | 2.44 | 2.32 | 2.20 | 2.28 |
| Quick ratioi | 2.09 | 1.46 | 1.46 | 1.32 | 1.24 | 1.24 |
| Debt / assetsi | 25.81 | 20.05 | 19.04 | 25.08 | 23.44 | 22.12 |
| LT debt / equityi | 42.44 | 31.07 | 29.26 | 42.43 | 38.73 | 36.24 |
| Interest coveragei | 3.82 | 3.93 | 4.46 | 2.69 | 2.73 | 2.67 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Sealing Technologies is the largest reported line at 63.81% of revenue, across 3 reported segments.
- Advanced Surface Technologies follows at 36.28%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Sealing Technologies63.81%
Advanced Surface Technologies36.28%
Quote time 2026-10-08 08:10:12 · For reference only, not investment advice and not tailored to your situation.